Industry reports
Editor highlights

Therapy

Summary

Table of Contents

  • Publication date: August 2010
Keywords : Therapy, biotherapeutics

Introduction This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. Features and benefits * Gain insight into Genzyme's strategic outlook across the next 6 years * Analyze company sa...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Therapy Industry : Latest Reports

Fragile X Syndrome - Pipeline Review, H2 2013

Fragile X Syndrome - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Fragile X Syndrome - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Fragile X Syndrome - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

Left Ventricular Dysfunction - Pipeline Review, H2 2013

Left Ventricular Dysfunction - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Left Ventricular Dysfunction - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Left Ventricular Dysfunction - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

Cellulite - Pipeline Review, H2 2013

December 2013 $ 2 000

Therapy Industry : Latest Downloads

Company Report: Therapeutics for Year 2014

  • Company report
  • March 2014
  • 60 pages

Company Report: Cancer Therapeutics for Year 2013

  • Company report
  • December 2013
  • 2 pages

... Interim analysis, including biomarker data, are being analyzed, and aveo and astellas are in discussions regarding next steps. About aveo aveo oncology (nasdaq: aveo) is a cancer therapeutics company ...

Company Report: Therapeutics for Year 2013

  • Company report
  • December 2013
  • 4 pages
  • by Corporation

... Five prime assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. Five prime therapeutics ...


More Reports:

Related Market Segments :

Biotherapeutics
Therapy

Company Reports

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.